SEP 14, 2019 03:25 PM PDT

Does Adderall Really Work for People without ADHD?

WRITTEN BY: Annie Lennon

Adderall is a popular stimulant. Known to treat Attention Deficit Disorder (ADHD), those without the condition also use it to increase attention, focus and to lengthen waking hours. In fact, estimates say that 20% of  Ivy League college students use the drug at least once during their college years (Loria: 2015). But does it really work for people without ADHD?

Despite Adderall’s reputation for “enhancing performance” research suggests that it instead only corrects deficits. For example, a study conducted at the University of Pennsylvania found that although led to some improvements for those who otherwise scored lower on cognitive ability tests, particularly in word recall, shape recognition and perception and abstract reasoning, its usage led to no improvements in cognitive functioning for already high-performing individuals (Ilieva: 2013). 

Similar results were found in a study measuring how Adderall affects people’s creativity: although there was some evidence that it may improve some areas of creativity for typically less creative people, for those considered more creative, Adderall either had no effect on their abilities, or even impaired them(Farah: 2008). But how? 

As people with ADHD tend to have less neural activity in areas of the brain responsible for executive function, such as working memory, attention and self-control, Adderall and similar medications work by increasing activity in these regions to recreate normal functioning. According to Lisa Weyandt, who has researched the neurocognitive effects of the drug, “If your brain is functioning normally in those regions, the medication is unlikely to have a positive effect on cognition and may actually impair cognition. In other words, you need to have a deficit to benefit from the medicine (University of Rhode Island: 2018).”

During research conducted in 2018, she found similar results when looking at the neurocognitive effects of Adderall in healthy people. A double-blind placebo-controlled study, 13 healthy college students aged 18- 24 were measured for cognitive ability both on Adderall and using a placebo. 

Although usage of the drug did tend to improve attention and focus, Weyandt and her team found that this did not lead to improved performance on tests for cognitive functioning, including short-term memory and reading comprehension, when compared to usage of a placebo. In fact, they found that it may have instead worsened their ability to recall lists of numbers and reduced their ability to self-regulate (ADHD Editorial Board: 2018). 

To conclude, Adderall may improve some elements of brain function for low-performing individuals even if they don’t have ADHD. Yet, for those who score higher on cognitive tests, Adderall is likely either have no effect, and may even impair their functioning. Thus, while taking it may somewhat help people who score low on cognitive tests to perform certain tasks, for those who already score relatively highly, the drug is likely to fail in meeting any expectations of improved cognition. 

 

Sources 

 

Loria, Kevin: Business Insider 

Ilieva, I: Pub Med

Farah, Martha J.: Psychopharmacology 

University of Rhode Island 

ADHD Editorial Board, Additude Mag

About the Author
  • Writer with a keen interest in genetics, psychology, health and everything in between. Currently focused on the interplay of genetics and society to understand how to create meaningful interactions and environments.
You May Also Like
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Gel Reduces Surgical Scarring
Scientists have found that spraying a gel on the internal tissues of animal post-surgery has significantly reduced scarring—which can often lead to d...
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Novel Drug Target for Dilating Microvessels
Medical scientists at Augusta University have discovered a natural occurring chemical that dilates blood vessels dilate as well as signaling larger blood v...
OCT 21, 2019
Neuroscience
OCT 21, 2019
Can CRISPR Technology Treat Alzheimer's?
New drugs that seek to treat Alzheimer’s disease (AD) have a 99.6% failure rate. This makes it the only disease in the top 10 causes of death that ca...
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Peptide-Based Therapeutics Advances Alzheimer Disease Research
Affecting 44 million individuals globally, Alzheimer’s disease (AD) is a form of dementia characterized by loss of brain cells, inflammation and vasc...
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Promising Drug for Prostate Cancer
Using high-throughput screening methods, cancer researchers from the UK have identified some promising drug candidates to test thousands of molecules. Spec...
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Common Drug May Prevent Thousands Deaths from Head Injury
Each year, there are over 60 million new cases of traumatic brain injury (TBI). Mostly caused by road traffic crashes and falls, TBI often causes intracran...
Loading Comments...